- Report
- March 2025
- 200 Pages
United States
From €2210EUR$2,490USD£1,920GBP
- Report
- May 2025
- 96 Pages
North America
From €4215EUR$4,750USD£3,662GBP
- Report
- April 2024
- 620 Pages
Global
From €6212EUR$7,000USD£5,397GBP
- Report
- March 2024
- 140 Pages
Global
From €4437EUR$5,000USD£3,855GBP
- Report
- December 2023
- 300 Pages
Global
From €3328EUR$3,750USD£2,891GBP
- Report
- April 2023
- 600 Pages
Global
From €5325EUR$6,000USD£4,626GBP
- Report
- February 2023
- 137 Pages
Global
From €4437EUR$5,000USD£3,855GBP
- Report
- November 2022
- 296 Pages
Global
From €4437EUR$5,000USD£3,855GBP
- Report
- March 2022
- 128 Pages
Global
From €4437EUR$5,000USD£3,855GBP
- Report
- February 2019
- 183 Pages
United States
From €3772EUR$4,250USD£3,277GBP
- Report
- July 2022
- 45 Pages
United States
From €4393EUR$4,950USD£3,816GBP
- Report
- December 2023
- 109 Pages
Global
From €5280EUR$5,950USD£4,587GBP
- Report
- January 2023
- 180 Pages
North America
From €5280EUR$5,950USD£4,587GBP
- Report
- January 2023
- 110 Pages
Global
From €5280EUR$5,950USD£4,587GBP
- Report
- August 2024
- 172 Pages
Global
From €2219EUR$2,500USD£1,927GBP
- Report
- July 2024
- 182 Pages
Global
From €3993EUR$4,500USD£3,469GBP
- Report
- July 2024
- 100 Pages
Global
From €3328EUR$3,750USD£2,891GBP
- Report
- July 2024
- 100 Pages
Global
From €3328EUR$3,750USD£2,891GBP
- Report
- July 2023
- 145 Pages
Global
From €2795EUR$3,150USD£2,429GBP
- Report
- February 2024
- 131 Pages
Global
From €4215EUR$4,750USD£3,662GBP

Point-of-Care (POC) Molecular Diagnostics is a rapidly growing field of medical diagnostics that enables the detection of genetic material from a patient sample at the point of care. This technology is used to detect and diagnose a wide range of diseases, including infectious diseases, cancer, and genetic disorders. POC Molecular Diagnostics offers a number of advantages over traditional laboratory-based testing, including faster turnaround times, improved accuracy, and cost savings.
POC Molecular Diagnostics is used in a variety of settings, including hospitals, clinics, and laboratories. It is also increasingly being used in home settings, allowing patients to self-test for a variety of conditions. This technology is also being used in the field of public health, allowing for rapid detection and response to outbreaks of infectious diseases.
Some companies in the POC Molecular Diagnostics market include Cepheid, Hologic, Abbott, and Roche. Show Less Read more